NEW YORK – Which stories gained the most attention from GenomeWeb's readers last week? Here are the top five:
- FDA Warning Letter to Agena Bioscience a 'Shot Across the Bow' for RUO-Labeled Diagnostics
- Multi-Cancer Screening Testmakers Share Updates at AACR as Field Grapples With Limitations
- Following Cuts, Singular Genomics Shifts Focus From NGS to Spatial Analysis
- Sweden's Single Technologies Progresses Towards 3D Sequencing, $10 Human Genome
- Delfi Diagnostics' Liquid Biopsy Technology Shows Promise for Ovarian Cancer Screening